Pre-Open Stock Movers 11/23: (CANF) (KBIO) (MNK) Higher; (PARR) (CAVM) (AGN) Lower (more...)
Tweet Send to a Friend
Can-Fite BioPharma (NYSE: CANF) 37.6% HIGHER; announced development of its drug candidate CF102, which is currently in Phase II trials ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE